Indra van Mourik

646 total citations
14 papers, 238 citations indexed

About

Indra van Mourik is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Indra van Mourik has authored 14 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Indra van Mourik's work include Liver Disease and Transplantation (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Indra van Mourik is often cited by papers focused on Liver Disease and Transplantation (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Indra van Mourik collaborates with scholars based in United Kingdom, Malaysia and Netherlands. Indra van Mourik's co-authors include Déirdre Kelly, Evangeline Wassmer, Khalid Sharif, Darius F. Mirza, M. Thamara P. R. Perera, Girish Gupte, Jane Hartley, Evelyn Ong, Sue V. Beath and Mitul Patel and has published in prestigious journals such as New England Journal of Medicine, Cochrane Database of Systematic Reviews and Transplantation.

In The Last Decade

Indra van Mourik

13 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Indra van Mourik United Kingdom 8 98 64 63 55 52 14 238
Joseph C. Yarze United States 8 152 1.6× 59 0.9× 77 1.2× 21 0.4× 12 0.2× 34 330
F. Castellino Italy 9 117 1.2× 70 1.1× 23 0.4× 76 1.4× 37 0.7× 12 357
J.E. Bull United Kingdom 7 75 0.8× 83 1.3× 89 1.4× 48 0.9× 15 0.3× 8 333
Federico Lari Italy 6 104 1.1× 170 2.7× 19 0.3× 50 0.9× 27 0.5× 30 304
Pedro Urruzuno Spain 14 541 5.5× 69 1.1× 50 0.8× 8 0.1× 64 1.2× 27 617
Nuray Uslu Türkiye 11 132 1.3× 70 1.1× 36 0.6× 64 1.2× 17 0.3× 22 298
Mohammed Hasosah Saudi Arabia 12 195 2.0× 66 1.0× 30 0.5× 103 1.9× 25 0.5× 51 368
Molly Bozic United States 7 70 0.7× 60 0.9× 15 0.2× 18 0.3× 13 0.3× 17 185
Erick Hernandez United States 8 207 2.1× 20 0.3× 194 3.1× 18 0.3× 8 0.2× 14 302
Brandy Lu United States 7 208 2.1× 74 1.2× 18 0.3× 8 0.1× 31 0.6× 9 293

Countries citing papers authored by Indra van Mourik

Since Specialization
Citations

This map shows the geographic impact of Indra van Mourik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indra van Mourik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indra van Mourik more than expected).

Fields of papers citing papers by Indra van Mourik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indra van Mourik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indra van Mourik. The network helps show where Indra van Mourik may publish in the future.

Co-authorship network of co-authors of Indra van Mourik

This figure shows the co-authorship network connecting the top 25 collaborators of Indra van Mourik. A scholar is included among the top collaborators of Indra van Mourik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indra van Mourik. Indra van Mourik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mourik, Indra van, et al.. (2024). P270 Can elexacaftor/tezacaftor/ivacaftor be prescribed in children with cystic fibrosis associated liver disease?. Journal of Cystic Fibrosis. 23. S151–S151.
2.
Mann, Jake P., Benjamin Jenkins, Samuel Furse, et al.. (2022). Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults. Journal of Pediatric Gastroenterology and Nutrition. 74(6). 734–741. 6 indexed citations
3.
Mourik, Indra van, Evelyn Ong, M. Thamara P. R. Perera, et al.. (2022). Acute‐on‐chronic liver failure: A 20‐year retrospective review of a tertiary paediatric liver centre. Acta Paediatrica. 111(7). 1435–1440. 3 indexed citations
4.
Gupte, Girish, Mitul Patel, Evelyn Ong, et al.. (2022). Clinical Spectrum of Children with Acute Hepatitis of Unknown Cause. New England Journal of Medicine. 387(7). 611–619. 60 indexed citations
5.
Mirza, Darius F., Paolo Muiesan, Evelyn Ong, et al.. (2022). Long‐term outcomes of pediatric liver transplantation using organ donation after circulatory death: Comparison between full and reduced grafts. Pediatric Transplantation. 26(8). e14385–e14385. 1 indexed citations
6.
Mourik, Indra van, et al.. (2020). Wilson disease in children and adolescents. Archives of Disease in Childhood. 105(5). 499–505. 44 indexed citations
7.
Mourik, Indra van, et al.. (2020). Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database of Systematic Reviews. 2020(3). 11 indexed citations
8.
Beath, Sue V., Bruce Morland, Jane Hartley, et al.. (2019). Comparison of Clinical Features and Outcome of Pediatric Posttransplant Lymphoproliferative Disorder in Recipients of Small Bowel Allograft Versus Isolated Liver Transplantation. Transplantation. 104(7). 1429–1436. 4 indexed citations
9.
Mann, Jake P., Anita Vreugdenhil, Piotr Socha, et al.. (2018). European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale. Contemporary Clinical Trials. 75. 67–71. 11 indexed citations
10.
Beath, Sue V., Jane Hartley, Déirdre Kelly, et al.. (2018). Septic Complications and Graft Outcome after Post-Transplant Lymphoproliferative Disorder in Paediatric Solid Organ Transplant Patients in the Rituximab Era. Transplantation. 102(Supplement 7). S458–S458. 1 indexed citations
11.
Moe, Soe, et al.. (2017). Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database of Systematic Reviews. 3. CD012056–CD012056. 16 indexed citations
12.
Dopazo, Cristina, Girish Gupte, Khalid Sharif, et al.. (2012). Combined Liver-Intestine Grafts Compared With Isolated Intestinal Transplantation in Children. Transplantation. 94(8). 859–865. 18 indexed citations
13.
Dowman, J. K., David Watson, Bridget Gunson, et al.. (2012). Long-Term Impact of Liver Transplantation on Respiratory Function and Nutritional Status in Children and Adults With Cystic Fibrosis. American Journal of Transplantation. 12(4). 954–964. 37 indexed citations
14.
Sharif, Khalid, Sue V. Beath, Déirdre Kelly, et al.. (2003). New perspective for the management of near-total or total intestinal aganglionosis in infants. Journal of Pediatric Surgery. 38(1). 25–28. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026